Compare SPIR & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPIR | HQL |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.0M | 490.5M |
| IPO Year | 2020 | N/A |
| Metric | SPIR | HQL |
|---|---|---|
| Price | $20.51 | $17.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.20 | N/A |
| AVG Volume (30 Days) | ★ 802.2K | 108.6K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | ★ 134.98 | N/A |
| EPS | ★ 1.49 | 0.79 |
| Revenue | ★ $110,451,000.00 | N/A |
| Revenue This Year | $8.69 | N/A |
| Revenue Next Year | $29.32 | N/A |
| P/E Ratio | ★ $10.45 | $21.46 |
| Revenue Growth | ★ 13.15 | N/A |
| 52 Week Low | $6.60 | $10.82 |
| 52 Week High | $16.55 | $17.80 |
| Indicator | SPIR | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 81.76 | 60.91 |
| Support Level | $8.05 | $16.40 |
| Resistance Level | N/A | $17.40 |
| Average True Range (ATR) | 1.68 | 0.35 |
| MACD | 0.62 | 0.11 |
| Stochastic Oscillator | 98.67 | 86.80 |
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.